Clinical Trial Update: Real-world Incidence of Intraocular Inflammation Following Intravitreal Faricimab Therapy

View source ↗

Summary

This completed study reports the real-world incidence of intraocular inflammation following intravitreal faricimab therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraocular Inflammation

Drugs mentioned

• VABYSMO (faricimab)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Intraocular Inflammation | Status: COMPLETED